The Doherty Institute's Sharon Lewin (Graham Hughes/The Canadian Press via AP Images)
From Australia, new $173M research center strives to be at the forefront of pandemic drug discovery
In the battle against Covid-19, vaccines came much earlier than therapeutics. A new research institution in Melbourne wants to change that.
Geoffrey Cumming, a Canadian-born oil and gas businessman, donated AUD $250 million ($173.63 million) to establish the Cumming Global Centre for Pandemic Therapeutics — whose mandate is to fund “an ambitious research program focusing on treatments that can be rapidly adapted after a new virus is identified.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
